Ozempic Lawsuit
2024
Ozempic class of drugs linked to rare but severe stomach problems, and possible blindness.
Aug. 2, 2023, in the U.S. District Court for the Western District of Louisiana, is the first to allege the medication can cause gastrointestinal injuries.
Learn More
Ozempic Lawsuit: New Lawsuits Filed Over Stomach Paralysis Claims
New Study Shows Injections Also Linked To Vision Loss And Potential Blindness.
Ozempic lawsuit
Numerous Ozempic lawsuits have been filed by patients who suffered severe and harmful symptoms. In several recent cases, the ailment affecting the plaintiff is gastroparesis, a paralysis of the stomach.
Every Ozempic lawsuit is filed against its manufacturer, Novo Nordisk. We are now also seeing a number of lawsuits filed against Mounjaro’s manufacturer, Eli Lilly, and Co. All federal Mounjaro or Ozempic lawsuits have been consolidated before Judge Pratter in the Eastern District of Pennsylvania.
Both drugs are regularly being used off-label for weight loss or as weight loss medications. Ozempic and Mounjaro were originally manufactured for diabetes therapy.
Each Ozempic lawsuit claims both blockbuster drugs are to blame for the plaintiff’s severe gastroparesis. These lawsuits are part of the coordinated litigation against Novo Nordisk (Ozempic) and Eli Lilly (Mounjaro), which are already facing litigation regarding gallstone risk.
Each plaintiff was using Ozempic or similar drugs to treat obesity and lose a significant amount of weight—as so many people in America have done. But, there was a darker outcome that they had no idea was coming. Ozempic, Wegovy, and similar drugs have been proven to cause serious gastrointestinal and gallbladder problems.
If you or someone you love has suffered stomach, intestinal, or gallbladder problems after using Ozempic, reach out to protect your legal rights today. Call us at 205-558-9000 or fill out our simple online form to schedule a free consultation.
New Study Shows Injections Also Linked To Vision Loss And Potential Blindness.
Linked to eye problems
Attention Ozempic users: There’s important news you need to know. Whether you’re taking this medication for diabetes management or weight loss, recent research has uncovered a potentially serious side effect that warrants your attention.
As if the already known risks of severe gastrointestinal issues, increased likelihood of gallstones, and possible mental health concerns weren’t enough, semaglutide users may now face an additional threat: Ozempic vision loss.
A groundbreaking study from Harvard University has shed light on a concerning link between medications that contain semaglutide, like Ozempic and Mounjaro, and a serious eye condition called NAION. Based on this new information, Wright and McCall is now investigating and accepting Ozempic vision loss lawsuit claims.
Let’s review the details of this research and its implications for Ozempic users.
A large study was recently published revealing that Ozempic and Wegovy (semaglutide) injections have significantly increased the risk of developing the condition NAION. This condition results in insufficient blood flow to the optic nerves. When blood vessels are blocked, you can lose your vision and go blind. Rybelsus is also a semaglutide, however, it is in a pill form. Similar injectable drugs, such as Mounjaro and Zepbound (tirzepatide) or Victoza and Saxenda (liraglutide), may also be shown to have similar side effects in the future.
Although Ozempic has been effective in aiding weight loss, this new information presents serious concerns. Since the start of this litigation, many attorneys have been hesitant to get involved. However, this study highlights serious risks that emphasize the need for thorough legal representation.